October 23, 2012 – The U.S. Preventive Services Task Force issued today its final recommendation statement on menopausal hormone therapy for the primary prevention of chronic conditions. To view the recommendation and the evidence on which it is based, please click here. A fact sheet that explains the final recommendation statement in plain language is also available on this Web page. The final recommendation can also be found in the October 23 online issue of Annals of Internal Medicine.
